Hallmarks of Cancer: The Next Generation

Adams, 2007, The Bcl-2 apoptotic switch in cancer development and therapy, Oncogene, 26, 1324, 10.1038/sj.onc.1210220

Aguirre-Ghiso, 2007, Models, mechanisms and clinical evidence for cancer dormancy, Nat. Rev. Cancer, 7, 834, 10.1038/nrc2256

Ahmed, 2009, Angiogenic signalling pathways, Methods Mol. Biol., 467, 3, 10.1007/978-1-59745-241-0_1

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100

Amaravadi, 2007, The roles of therapy-induced autophagy and necrosis in cancer treatment, Clin. Cancer Res., 13, 7271, 10.1158/1078-0432.CCR-07-1595

Amit, 2007, A module of negative feedback regulators defines growth factor signaling, Nat. Genet., 39, 503, 10.1038/ng1987

Apel, 2009, Autophagy-A double-edged sword in oncology, Int. J. Cancer, 125, 991, 10.1002/ijc.24500

Artandi, 2000, Mice without telomerase: what can they teach us about human cancer?, Nat. Med., 6, 852, 10.1038/78595

Artandi, 2010, Telomeres and telomerase in cancer, Carcinogenesis, 31, 9, 10.1093/carcin/bgp268

Azam, 2010, Mechanisms of resistance to antiangiogenesis therapy, Eur. J. Cancer, 46, 1323, 10.1016/j.ejca.2010.02.020

Baeriswyl, 2009, The angiogenic switch in carcinogenesis, Semin. Cancer Biol., 19, 329, 10.1016/j.semcancer.2009.05.003

Baluk, 2005, Cellular abnormalities of blood vessels as targets in cancer, Curr. Opin. Genet. Dev., 15, 102, 10.1016/j.gde.2004.12.005

Barkan, 2010, Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth, Eur. J. Cancer, 46, 1181, 10.1016/j.ejca.2010.02.027

Barnes, 2004, Repair and genetic consequences of endogenous DNA base damage in mammalian cells, Annu. Rev. Genet., 38, 445, 10.1146/annurev.genet.38.072902.092448

Barrallo-Gimeno, 2005, The Snail genes as inducers of cell movement and survival: implications in development and cancer, Development, 132, 3151, 10.1242/dev.01907

Berdasco, 2010, Aberrant epigenetic landscape in cancer: How cellular identity goes awry, Dev. Cell, 19, 698, 10.1016/j.devcel.2010.10.005

Bergers, 2003, Tumorigenesis and the angiogenic switch, Nat. Rev. Cancer, 3, 401, 10.1038/nrc1093

Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat. Rev. Cancer, 8, 592, 10.1038/nrc2442

Bergers, 2005, The role of pericytes in blood-vessel formation and maintenance, Neuro-oncol., 7, 452, 10.1215/S1152851705000232

Bergfeld, 2010, Bone marrow-derived mesenchymal stem cells and the tumor microenvironment, Cancer Metastasis Rev., 29, 249, 10.1007/s10555-010-9222-7

Berx, 2009, Involvement of members of the cadherin superfamily in cancer, Cold Spring Harb. Perspect. Biol., 1, a003129, 10.1101/cshperspect.a003129

Bhowmick, 2004, Stromal fibroblasts in cancer initiation and progression, Nature, 432, 332, 10.1038/nature03096

Bierie, 2006, Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer, Nat. Rev. Cancer, 6, 506, 10.1038/nrc1926

Bindea, 2010, Natural immunity to cancer in humans, Curr. Opin. Immunol., 22, 215, 10.1016/j.coi.2010.02.006

Biswas, 2010, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nat. Immunol., 11, 889, 10.1038/ni.1937

Blasco, 2005, Telomeres and human disease: ageing, cancer and beyond, Nat. Rev. Genet., 6, 611, 10.1038/nrg1656

Boiko, 2010, Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 133, 10.1038/nature09161

Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730

Bos, 2009, Genes that mediate breast cancer metastasis to the brain, Nature, 459, 1005, 10.1038/nature08021

Brabletz, 2001, Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment, Proc. Natl. Acad. Sci. USA, 98, 10356, 10.1073/pnas.171610498

Brabletz, 2005, Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression, Nat. Rev. Cancer, 5, 744, 10.1038/nrc1694

Buck, 2007, Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition, Mol. Cancer Ther., 6, 532, 10.1158/1535-7163.MCT-06-0462

Burkhart, 2008, Cellular mechanisms of tumour suppression by the retinoblastoma gene, Nat. Rev. Cancer, 8, 671, 10.1038/nrc2399

Cabrita, 2008, Sprouty proteins, masterminds of receptor tyrosine kinase signaling, Angiogenesis, 11, 53, 10.1007/s10456-008-9089-1

Campbell, 2010, The patterns and dynamics of genomic instability in metastatic pancreatic cancer, Nature, 467, 1109, 10.1038/nature09460

Cao, 2010, Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases, Nat. Rev. Drug Discov., 9, 107, 10.1038/nrd3055

Carmeliet, 2005, VEGF as a key mediator of angiogenesis in cancer, Oncology, 69, 4, 10.1159/000088478

Carmeliet, 2000, Angiogenesis in cancer and other diseases, Nature, 407, 249, 10.1038/35025220

Cavallaro, 2004, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer, Nat. Rev. Cancer, 4, 118, 10.1038/nrc1276

Cheng, 2008, Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion, Mol. Cancer Res., 6, 1521, 10.1158/1541-7786.MCR-07-2203

Chin, 2004, In situ analyses of genome instability in breast cancer, Nat. Genet., 36, 984, 10.1038/ng1409

Cho, 2008, Recent advances in cancer stem cells, Curr. Opin. Genet. Dev., 18, 1, 10.1016/j.gde.2008.01.017

Ciccia, 2010, The DNA damage response: making it safe to play with knives, Mol. Cell, 40, 179, 10.1016/j.molcel.2010.09.019

Coffelt, 2010, Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors, Am. J. Pathol., 176, 1564, 10.2353/ajpath.2010.090786

Coghlin, 2010, Current and emerging concepts in tumour metastasis, J. Pathol., 222, 1, 10.1002/path.2727

Collado, 2010, Senescence in tumours: evidence from mice and humans, Nat. Rev. Cancer, 10, 51, 10.1038/nrc2772

Colotta, 2009, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, 30, 1073, 10.1093/carcin/bgp127

Cong, 2008, Actions of human telomerase beyond telomeres, Cell Res., 18, 725, 10.1038/cr.2008.74

Creighton, 2009, Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features, Proc. Natl. Acad. Sci. USA, 106, 13820, 10.1073/pnas.0905718106

Curto, 2007, Contact-dependent inhibition of EGFR signaling by Nf2/Merlin, J. Cell Biol., 177, 893, 10.1083/jcb.200703010

Davies, 2010, Analysis of the genome to personalize therapy for melanoma, Oncogene, 29, 5545, 10.1038/onc.2010.323

DeBerardinis, 2008, The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002

Dejana, 2009, Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees, Cell Tissue Res., 335, 17, 10.1007/s00441-008-0694-5

Demicheli, 2008, The effects of surgery on tumor growth: a century of investigations, Ann. Oncol., 19, 1821, 10.1093/annonc/mdn386

DeNardo, 2010, Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity, Cancer Metastasis Rev., 29, 309, 10.1007/s10555-010-9223-6

De Palma, 2007, Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications, Trends Immunol., 28, 519, 10.1016/j.it.2007.09.004

Deshpande, 2005, Cyclins and cdks in development and cancer: a perspective, Oncogene, 24, 2909, 10.1038/sj.onc.1208618

de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat. Rev. Cancer, 6, 24, 10.1038/nrc1782

Dirat, 2010, Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes?, Endocr. Dev., 19, 45, 10.1159/000316896

Dvorak, 1986, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing, N. Engl. J. Med., 315, 1650, 10.1056/NEJM198612253152606

Ebos, 2009, Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy, Clin. Cancer Res., 15, 5020, 10.1158/1078-0432.CCR-09-0095

Egeblad, 2010, Tumors as organs: complex tissues that interface with the entire organism, Dev. Cell, 18, 884, 10.1016/j.devcel.2010.05.012

El Hallani, 2010, A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry, Brain, 133, 973, 10.1093/brain/awq044

Ellis, 2009, Cancer: The nuances of therapy, Nature, 458, 290, 10.1038/458290a

Esteller, 2007, Cancer epigenomics: DNA methylomes and histone-modification maps, Nat. Rev. Genet., 8, 286, 10.1038/nrg2005

Evan, 2009, Cellular senescence: hot or what?, Curr. Opin. Genet. Dev., 19, 25, 10.1016/j.gde.2008.11.009

Evan, 1998, A matter of life and cell death, Science, 281, 1317, 10.1126/science.281.5381.1317

Fang, 2011, Stem cells in tumor angiogenesis, J. Mol. Cell. Cardiol., 50, 290, 10.1016/j.yjmcc.2010.10.024

Feron, 2009, Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells, Radiother. Oncol., 92, 329, 10.1016/j.radonc.2009.06.025

Feldser, 2007, Short telomeres limit tumor progression in vivo by inducing senescence, Cancer Cell, 11, 461, 10.1016/j.ccr.2007.02.026

Ferrara, 2009, Vascular endothelial growth factor, Arterioscler. Thromb. Vasc. Biol., 29, 789, 10.1161/ATVBAHA.108.179663

Ferrara, 2010, Pathways mediating VEGF-independent tumor angiogenesis, Cytokine Growth Factor Rev., 21, 21, 10.1016/j.cytogfr.2009.11.003

Ferrone, 2010, Dual roles for immunity in gastrointestinal cancers, J. Clin. Oncol., 28, 4045, 10.1200/JCO.2010.27.9992

Fidler, 2003, The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited, Nat. Rev. Cancer, 3, 453, 10.1038/nrc1098

Folkman, 2002, Role of angiogenesis in tumor growth and metastasis, Semin. Oncol., 29, 15, 10.1016/S0093-7754(02)70065-1

Folkman, 2006, Angiogenesis, Annu. Rev. Med., 57, 1, 10.1146/annurev.med.57.121304.131306

Folkman, 2004, Cancer without disease, Nature, 427, 787, 10.1038/427787a

Friedberg, 2006, DNA repair: from molecular mechanism to human disease, DNA Repair (Amst.), 5, 986, 10.1016/j.dnarep.2006.05.005

Friedl, 2008, Tube travel: the role of proteases in individual and collective cancer cell invasion, Cancer Res., 68, 7247, 10.1158/0008-5472.CAN-08-0784

Friedl, 2010, Plasticity of cell migration: a multiscale tuning model, J. Cell Biol., 188, 11, 10.1083/jcb.200909003

Gaengel, 2009, Endothelial-mural cell signaling in vascular development and angiogenesis, Arterioscler. Thromb. Vasc. Biol., 29, 630, 10.1161/ATVBAHA.107.161521

Galluzzi, 2008, Necroptosis: a specialized pathway of programmed necrosis, Cell, 135, 1161, 10.1016/j.cell.2008.12.004

Garzon, 2010, Targeting microRNAs in cancer: rationale, strategies and challenges, Nat. Rev. Drug Discov., 9, 775, 10.1038/nrd3179

Gerhardt, 2008, Pericytes: gatekeepers in tumour cell metastasis?, J. Mol. Med., 86, 135, 10.1007/s00109-007-0258-2

Ghebranious, 1998, Mouse models in tumor suppression, Oncogene, 17, 3385, 10.1038/sj.onc.1202573

Giaccia, 2010, Role of carcinoma-associated fibroblasts and hypoxia in tumor progression, Curr. Top. Microbiol. Immunol., 345, 31

Gilbertson, 2007, Making a tumour's bed: glioblastoma stem cells and the vascular niche, Nat. Rev. Cancer, 7, 733, 10.1038/nrc2246

Gocheva, 2010, IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion, Genes Dev., 24, 241, 10.1101/gad.1874010

Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025

Gupta, 2005, Identifying site-specific metastasis genes and functions, Cold Spring Harb. Symp. Quant. Biol., 70, 149, 10.1101/sqb.2005.70.018

Gupta, 2009, Cancer stem cells: mirage or reality?, Nat. Med., 15, 1010, 10.1038/nm0909-1010

Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Hansel, 2006, Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma, Mod. Pathol., 19, 772, 10.1038/modpathol.3800591

Hardee, 2009, Novel imaging provides new insights into mechanisms of oxygen transport in tumors, Curr. Mol. Med., 9, 435, 10.2174/156652409788167122

Harper, 2007, The DNA damage response: Ten years after, Mol. Cell, 28, 739, 10.1016/j.molcel.2007.11.015

Hezel, 2008, LKB1; linking cell structure and tumor suppression, Oncogene, 27, 6908, 10.1038/onc.2008.342

Hlubek, 2007, Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer, Int. J. Cancer, 121, 1941, 10.1002/ijc.22916

Hugo, 2007, Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression, J. Cell. Physiol., 213, 374, 10.1002/jcp.21223

Hsu, 2008, Cancer cell metabolism: Warburg and beyond, Cell, 134, 703, 10.1016/j.cell.2008.08.021

Hynes, 2009, ErbB receptors and signaling pathways in cancer, Curr. Opin. Cell Biol., 21, 177, 10.1016/j.ceb.2008.12.010

Ikushima, 2010, TGFbeta signalling: a complex web in cancer progression, Nat. Rev. Cancer, 10, 415, 10.1038/nrc2853

Ince, 2007, Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes, Cancer Cell, 12, 160, 10.1016/j.ccr.2007.06.013

Jackson, 2009, The DNA-damage response in human biology and disease, Nature, 461, 1071, 10.1038/nature08467

Jiang, 2009, PI3K/PTEN signaling in angiogenesis and tumorigenesis, Adv. Cancer Res., 102, 19, 10.1016/S0065-230X(09)02002-8

Johansson, 2008, Polarized immune responses differentially regulate cancer development, Immunol. Rev., 222, 145, 10.1111/j.1600-065X.2008.00600.x

Jones, 2007, The epigenomics of cancer, Cell, 128, 683, 10.1016/j.cell.2007.01.029

Jones, 2009, Tumor suppressors and cell metabolism: a recipe for cancer growth, Genes Dev., 23, 537, 10.1101/gad.1756509

Joyce, 2009, Microenvironmental regulation of metastasis, Nat. Rev. Cancer, 9, 239, 10.1038/nrc2618

Junttila, 2009, p53—a Jack of all trades but master of none, Nat. Rev. Cancer, 9, 821, 10.1038/nrc2728

Kalluri, 2006, Fibroblasts in cancer, Nat. Rev. Cancer, 6, 392, 10.1038/nrc1877

Kang, 2004, Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity, J. Neurosci., 24, 1280, 10.1523/JNEUROSCI.4082-03.2004

Karin, 2006, Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer, Cell, 124, 823, 10.1016/j.cell.2006.02.016

Karnoub, 2006, Chemokine networks and breast cancer metastasis, Breast Dis., 26, 75, 10.3233/BD-2007-26107

Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038/nature06188

Kastan, 2008, DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture, Mol. Cancer Res., 6, 517, 10.1158/1541-7786.MCR-08-0020

Kawai, 2007, Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung, Am. J. Clin. Pathol., 127, 254, 10.1309/91PY0RBD9W8Y5GNX

Kazerounian, 2008, Thrombospondins in cancer, Cell. Mol. Life Sci., 65, 700, 10.1007/s00018-007-7486-z

Kenific, 2010, Autophagy and metastasis: another double-edged sword, Curr. Opin. Cell Biol., 22, 241, 10.1016/j.ceb.2009.10.008

Kennedy, 2010, Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation, Future Oncol., 6, 127, 10.2217/fon.09.145

Kessenbrock, 2010, Matrix metalloproteinases: Regulators of the tumor microenvironment, Cell, 141, 52, 10.1016/j.cell.2010.03.015

Kim, 2009, Tumor self-seeding by circulating cancer cells, Cell, 139, 1315, 10.1016/j.cell.2009.11.025

Kim, 2007, Cancer immunoediting from immune surveillance to immune escape, Immunology, 121, 1, 10.1111/j.1365-2567.2007.02587.x

Kinzler, 1997, Cancer-susceptibility genes. Gatekeepers and caretakers, Nature, 386, 761, 10.1038/386761a0

Klein, 2009, Parallel progression of primary tumours and metastases, Nat. Rev. Cancer, 9, 302, 10.1038/nrc2627

Klymkowsky, 2009, Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe, Am. J. Pathol., 174, 1588, 10.2353/ajpath.2009.080545

Korkola, 2010, Breast cancer genomes—form and function, Curr. Opin. Genet. Dev., 20, 4, 10.1016/j.gde.2009.11.005

Kovacic, 2009, Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology, Stem Cell Res. (Amst.), 2, 2, 10.1016/j.scr.2008.05.005

Kroemer, 2008, Tumor cell metabolism: Cancer's Achilles' heel, Cancer Cell, 13, 472, 10.1016/j.ccr.2008.05.005

Lamagna, 2006, The bone marrow constitutes a reservoir of pericyte progenitors, J. Leukoc. Biol., 80, 677, 10.1189/jlb.0506309

Lane, 1992, Cancer. p53, guardian of the genome, Nature, 358, 15, 10.1038/358015a0

Lemmon, 2010, Cell signaling by receptor tyrosine kinases, Cell, 141, 1117, 10.1016/j.cell.2010.06.011

Levine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016/j.cell.2007.12.018

Lipinski, 1999, The retinoblastoma gene family in differentiation and development, Oncogene, 18, 7873, 10.1038/sj.onc.1203244

Lobo, 2007, The biology of cancer stem cells, Annu. Rev. Cell Dev. Biol., 23, 675, 10.1146/annurev.cellbio.22.010305.104154

Lowe, 2004, Intrinsic tumour suppression, Nature, 432, 307, 10.1038/nature03098

Luebeck, 2010, Cancer: Genomic evolution of metastasis, Nature, 467, 1053, 10.1038/4671053a

Lu, 2008, The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells, J. Clin. Invest., 118, 3917

Luo, 2009, Principles of cancer therapy: Oncogene and non-oncogene addiction, Cell, 136, 823, 10.1016/j.cell.2009.02.024

Mac Gabhann, 2008, Systems biology of vascular endothelial growth factors, Microcirculation, 15, 715, 10.1080/10739680802095964

Madsen, 2010, Cancer dissemination—Lessons from leukocytes, Dev. Cell, 19, 13, 10.1016/j.devcel.2010.06.013

Maida, 2009, An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA, Nature, 461, 230, 10.1038/nature08283

Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027

Mantovani, 2010, Molecular pathways linking inflammation and cancer, Curr. Mol. Med., 10, 369, 10.2174/156652410791316968

Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205

Massagué, 2008, TGFβ in cancer, Cell, 134, 215, 10.1016/j.cell.2008.07.001

Masutomi, 2005, The telomerase reverse transcriptase regulates chromatin state and DNA damage responses, Proc. Natl. Acad. Sci. USA, 102, 8222, 10.1073/pnas.0503095102

Mathew, 2007, Role of autophagy in cancer, Nat. Rev. Cancer, 7, 961, 10.1038/nrc2254

McGowan, 2009, Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches, Future Oncol., 5, 1083, 10.2217/fon.09.73

Micalizzi, 2010, Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression, J. Mammary Gland Biol. Neoplasia, 15, 117, 10.1007/s10911-010-9178-9

Mizushima, 2007, Autophagy: process and function, Genes Dev., 21, 2861, 10.1101/gad.1599207

Mohamed, 2006, Cysteine cathepsins: multifunctional enzymes in cancer, Nat. Rev. Cancer, 6, 764, 10.1038/nrc1949

Mooi, 2006, Oncogene-induced cell senescence—halting on the road to cancer, N. Engl. J. Med., 355, 1037, 10.1056/NEJMra062285

Morel, 2008, Generation of breast cancer stem cells through epithelial-mesenchymal transition, PLoS ONE, 3, e2888, 10.1371/journal.pone.0002888

Mosesson, 2008, Derailed endocytosis: an emerging feature of cancer, Nat. Rev. Cancer, 8, 835, 10.1038/nrc2521

Mougiakakos, 2010, Regulatory T cells in cancer, Adv. Cancer Res., 107, 57, 10.1016/S0065-230X(10)07003-X

Murdoch, 2008, The role of myeloid cells in the promotion of tumour angiogenesis, Nat. Rev. Cancer, 8, 618, 10.1038/nrc2444

Nagy, 2010, Heterogeneity of the tumor vasculature, Semin. Thromb. Hemost., 36, 321, 10.1055/s-0030-1253454

Naumov, 2008, Tumor-vascular interactions and tumor dormancy, APMIS, 116, 569, 10.1111/j.1600-0463.2008.01213.x

Negrini, 2010, Genomic instability—an evolving hallmark of cancer, Nat. Rev. Mol. Cell Biol., 11, 220, 10.1038/nrm2858

Nelson, 2008, The impact of T-cell immunity on ovarian cancer outcomes, Immunol. Rev., 222, 101, 10.1111/j.1600-065X.2008.00614.x

Nguyen, 2009, Metastasis: from dissemination to organ-specific colonization, Nat. Rev. Cancer, 9, 274, 10.1038/nrc2622

Norden, 2009, Antiangiogenic therapies for high-grade glioma, Nat. Rev. Neurol., 5, 610, 10.1038/nrneurol.2009.159

Nyberg, 2005, Endogenous inhibitors of angiogenesis, Cancer Res., 65, 3967, 10.1158/0008-5472.CAN-04-2427

Okada, 2005, Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane, J. Cell Biol., 171, 361, 10.1083/jcb.200503165

Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362

Olson, 2009, MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer, Genes Dev., 23, 2152, 10.1101/gad.1820109

O'Reilly, 2006, mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt, Cancer Res., 66, 1500, 10.1158/0008-5472.CAN-05-2925

Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: linking inflammation and cancer, J. Immunol., 182, 4499, 10.4049/jimmunol.0802740

Pagès, 2010, Immune infiltration in human tumors: a prognostic factor that should not be ignored, Oncogene, 29, 1093, 10.1038/onc.2009.416

Palermo, 2008, Cysteine cathepsin proteases as pharmacological targets in cancer, Trends Pharmacol. Sci., 29, 22, 10.1016/j.tips.2007.10.011

Park, 2009, Telomerase modulates Wnt signalling by association with target gene chromatin, Nature, 460, 66, 10.1038/nature08137

Partanen, 2009, 3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc, Cell Cycle, 8, 716, 10.4161/cc.8.5.7786

Pasquale, 2010, Eph receptors and ephrins in cancer: bidirectional signalling and beyond, Nat. Rev. Cancer, 10, 165, 10.1038/nrc2806

Passos, 2007, DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?, Nucleic Acids Res., 35, 7505, 10.1093/nar/gkm893

Patenaude, 2010, Involvement of endothelial progenitor cells in tumor vascularization, Microvasc. Res., 79, 217, 10.1016/j.mvr.2010.01.007

Peinado, 2011, The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts, Semin. Cancer Biol., 10.1016/j.semcancer.2011.01.002

Peinado, 2004, Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo, J. Cell Sci., 117, 2827, 10.1242/jcs.01145

Perona, 2006, Cell signalling: growth factors and tyrosine kinase receptors, Clin. Transl. Oncol., 8, 77, 10.1007/s12094-006-0162-1

Pietras, 2010, Hallmarks of cancer: interactions with the tumor stroma, Exp. Cell Res., 316, 1324, 10.1016/j.yexcr.2010.02.045

Polyak, 2009, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nat. Rev. Cancer, 9, 265, 10.1038/nrc2620

Polyak, 2009, Co-evolution of tumor cells and their microenvironment, Trends Genet., 25, 30, 10.1016/j.tig.2008.10.012

Potter, 1958, The biochemical approach to the cancer problem, Fed. Proc., 17, 691

Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014

Quintana, 2008, Efficient tumour formation by single human melanoma cells, Nature, 456, 593, 10.1038/nature07567

Raica, 2009, Angiogenesis in pre-malignant conditions, Eur. J. Cancer, 45, 1924, 10.1016/j.ejca.2009.04.007

Räsänen, 2010, Activation of fibroblasts in cancer stroma, Exp. Cell Res., 316, 2713, 10.1016/j.yexcr.2010.04.032

Raynaud, 2010, DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer, Am. J. Clin. Oncol., 33, 341, 10.1097/COC.0b013e3181b0c4c2

Raza, 2010, Pericytes and vessel maturation during tumor angiogenesis and metastasis, Am. J. Hematol., 85, 593, 10.1002/ajh.21745

Reitman, 2010, Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism, J. Natl. Cancer Inst., 102, 932, 10.1093/jnci/djq187

Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167

Ribatti, 2009, Endogenous inhibitors of angiogenesis: a historical review, Leuk. Res., 33, 638, 10.1016/j.leukres.2008.11.019

Ricci-Vitiani, 2010, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, Nature, 468, 824, 10.1038/nature09557

Ruoslahti, 2002, Specialization of tumour vasculature, Nat. Rev. Cancer, 2, 83, 10.1038/nrc724

Ruoslahti, 2010, Targeting of drugs and nanoparticles to tumors, J. Cell Biol., 188, 759, 10.1083/jcb.200910104

Sabeh, 2009, Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited, J. Cell Biol., 185, 11, 10.1083/jcb.200807195

Salk, 2010, Mutational heterogeneity in human cancers: origin and consequences, Ann. Rev. Pathol., 5, 51, 10.1146/annurev-pathol-121808-102113

Schäfer, 2008, Cancer as an overhealing wound: an old hypothesis revisited, Nat. Rev. Mol. Cell Biol., 9, 628, 10.1038/nrm2455

Schmalhofer, 2009, E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer, Cancer Metastasis Rev., 28, 151, 10.1007/s10555-008-9179-y

Semenza, 2008, Tumor metabolism: cancer cells give and take lactate, J. Clin. Invest., 118, 3835

Semenza, 2010, HIF-1: upstream and downstream of cancer metabolism, Curr. Opin. Genet. Dev., 20, 51, 10.1016/j.gde.2009.10.009

Semenza, 2010, Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics, Oncogene, 29, 625, 10.1038/onc.2009.441

Seppinen, 2008, Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing, Matrix Biol., 27, 535, 10.1016/j.matbio.2008.03.003

Shaw, 2009, Tumor suppression by LKB1: SIK-ness prevents metastasis, Sci. Signal., 2, pe55, 10.1126/scisignal.286pe55

Shay, 2000, Hayflick, his limit, and cellular ageing, Nat. Rev. Mol. Cell Biol., 1, 72, 10.1038/35036093

Sherr, 2000, Cellular senescence: Mitotic clock or culture shock?, Cell, 102, 407, 10.1016/S0092-8674(00)00046-5

Sherr, 2002, The RB and p53 pathways in cancer, Cancer Cell, 2, 103, 10.1016/S1535-6108(02)00102-2

Shields, 2010, Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21, Science, 328, 749, 10.1126/science.1185837

Shimoda, 2010, Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression, Semin. Cell Dev. Biol., 21, 19, 10.1016/j.semcdb.2009.10.002

Sigal, 2000, Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome, Cancer Res., 60, 6788

Singh, 2010, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, 29, 4741, 10.1038/onc.2010.215

Sinha, 2008, The autophagy effector Beclin 1: a novel BH3-only protein, Oncogene, 27, S137, 10.1038/onc.2009.51

Smyth, 2006, Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity, Adv. Immunol., 90, 1, 10.1016/S0065-2776(06)90001-7

Soda, 2011, Feature Article: Transdifferentiation of glioblastoma cells into vascular endothelial cells, Proc. Natl. Acad. Sci. USA, 10.1073/pnas.1016030108

Sudarsanam, 2010, Functional consequences of mTOR inhibition, Curr. Opin. Drug Discov. Devel., 13, 31

Strauss, 2010, Transmission of donor melanoma by organ transplantation, Lancet Oncol., 11, 790, 10.1016/S1470-2045(10)70024-3

Talmadge, 2010, AACR centennial series: the biology of cancer metastasis: historical perspective, Cancer Res., 70, 5649, 10.1158/0008-5472.CAN-10-1040

Tammela, 2010, Lymphangiogenesis: Molecular mechanisms and future promise, Cell, 140, 460, 10.1016/j.cell.2010.01.045

Taube, 2010, Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes, Proc. Natl. Acad. Sci. USA, 107, 15449, 10.1073/pnas.1004900107

Teng, 2008, Immune-mediated dormancy: an equilibrium with cancer, J. Leukoc. Biol., 84, 988, 10.1189/jlb.1107774

Thiery, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat. Rev. Mol. Cell Biol., 7, 131, 10.1038/nrm1835

Thiery, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007

Townson, 2006, Dormancy of solitary metastatic cells, Cell Cycle, 5, 1744, 10.4161/cc.5.16.2864

Turner, 2003, Angiogenesis in endocrine tumors, Endocr. Rev., 24, 600, 10.1210/er.2002-0008

Vajdic, 2009, Cancer incidence and risk factors after solid organ transplantation, Int. J. Cancer, 125, 1747, 10.1002/ijc.24439

Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809

Verhoeff, 2009, Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme, BMC Cancer, 9, 444, 10.1186/1471-2407-9-444

Wang, 2010, Glioblastoma stem-like cells give rise to tumour endothelium, Nature, 468, 829, 10.1038/nature09624

Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309

Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269

Warburg, 1930

Wertz, 2010, Regulation of death receptor signaling by the ubiquitin system, Cell Death Differ., 17, 14, 10.1038/cdd.2009.168

White, 2010, Role of autophagy in suppression of inflammation and cancer, Curr. Opin. Cell Biol., 22, 212, 10.1016/j.ceb.2009.12.008

White, 2009, The double-edged sword of autophagy modulation in cancer, Clin. Cancer Res., 15, 5308, 10.1158/1078-0432.CCR-07-5023

Willis, 2005, Life in the balance: how BH3-only proteins induce apoptosis, Curr. Opin. Cell Biol., 17, 617, 10.1016/j.ceb.2005.10.001

Witsch, 2010, Roles for growth factors in cancer progression, Physiology (Bethesda), 25, 85

Wyckoff, 2007, Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors, Cancer Res., 67, 2649, 10.1158/0008-5472.CAN-06-1823

Yachida, 2010, Distant metastasis occurs late during the genetic evolution of pancreatic cancer, Nature, 467, 1114, 10.1038/nature09515

Yang, 2008, Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis, Dev. Cell, 14, 818, 10.1016/j.devcel.2008.05.009

Yang, 2010, TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression, Trends Immunol., 31, 220, 10.1016/j.it.2010.04.002

Yen, 2010, Cancer-associated IDH mutations: biomarker and therapeutic opportunities, Oncogene, 29, 6409, 10.1038/onc.2010.444

Yilmaz, 2009, EMT, the cytoskeleton, and cancer cell invasion, Cancer Metastasis Rev., 28, 15, 10.1007/s10555-008-9169-0

Yuan, 2008, PI3K pathway alterations in cancer: variations on a theme, Oncogene, 27, 5497, 10.1038/onc.2008.245

Zee, 2010, Imaging angiogenesis of genitourinary tumors, Nat. Rev. Urol., 7, 69, 10.1038/nrurol.2009.262

Zhang, 2004, Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions, Oncogene, 23, 6193, 10.1038/sj.onc.1207834

Zong, 2006, Necrotic death as a cell fate, Genes Dev., 20, 1, 10.1101/gad.1376506

Zumsteg, 2009, Corrupt policemen: inflammatory cells promote tumor angiogenesis, Curr. Opin. Oncol., 21, 60, 10.1097/CCO.0b013e32831bed7e